Structure-activity relationships in nucleotide oligomerization domain 1 (Nod1) agonistic γ-glutamyldiaminopimelic acid derivatives.
Structure-activity relationships in nucleotide oligomerization domain 1 (Nod1) agonistic γ-glutamyldiaminopimelic acid derivatives.
复制标题
DOI:
10.1021/jm101535e
复制
发表时间:
2011-03-10
影响因子:
7.3
通讯作者:
David SA
中科院分区:
文献类型:
--
作者:
Agnihotri G;Ukani R;Malladi SS;Warshakoon HJ;Balakrishna R;Wang X;David SA
N-acyl-γ-glutamyl-diaminopimelic acid is a prototype ligand for Nod1. We report a detailed SAR of C12-γ-D-Glu-DAP. Analogues with glutaric or γ-aminobutyric acid replacing the glutamic acid show greatly attenuated Nod1-agonistic activity. Substitution of the meso-diaminopimelic (DAP) acid component with monoaminopimelic acid, L- or D-lysine, or cadaverine also results in reduced activity. The free amine on DAP is crucial. However, the N-acyl group on the D-glutamyl residue can be substituted with N-alkyl groups with full preservation of activity. The free carboxylates on the DAP and Glu components can also be esterified, resulting in more lipophilic, but active analogues. Transcriptomal profiling showed a dominant upregulation of IL-19, IL-20, IL-22, and IL-24, which may explain the pronounced Th2-polarizing activity of these compounds, and also implicate cell signaling mediated by TREM-1. These results may explain the hitherto unknown mechanism of synergy between Nod1- and TLR-agonists, and are likely to be useful in designing vaccine adjuvants.
登录
查看更多内容
影响因子:
56.9
作者:
HAN, J;LEE, JD;ULEVITCH, RJ
通讯作者:
ULEVITCH, RJ
影响因子:
3.3
作者:
IZUMI, S;NAKAHARA, K;IMANAKA, H
通讯作者:
IMANAKA, H
影响因子:
8.7
作者:
Franchi L;Warner N;Viani K;Nuñez G
通讯作者:
Nuñez G
DOI:
10.4161/hv.6.4.10866
发表时间:
2010-04-01
期刊:
HUMAN VACCINES
影响因子:
--
作者:
Hood, Jennifer D.;Warshakoon, Hemamali J.;David, Sunil A.
通讯作者:
David, Sunil A.
影响因子:
64.8
作者:
Bouchon, A;Facchetti, F;Colonna, M
通讯作者:
Colonna, M